Studying HLA class I polymorphism in brain tumour patients
Baghdad Science Journal, ISSN: 2078-8665, Vol: 9, Issue: 3, Page: 481-490
2012
- 4Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage4
- Downloads4
Article Description
The present study aimed at shed light on the association between HLA-class I antigens (A, B and Cw) and brain tumours (meningioma and glioma) in the basis of their individual frequencies or two-locus association A total of 52 brain tumour patients were enrolled in this study, with an age range of 7-68 years. The patients were divided into two clinical groups; meningioma (20 cases) and glioma (22 cases), while the remaining 10 cases represented other types of brain tumour. Control samples included 47 Iraqi Arab apparently healthy blood volunteers, with an age range of 15-50 year. Three HLA antigens showed a significant increased frequency in total patients as compared to controls. They were B13 (34.6 vs. 6.5%), B40 (15.4 vs. 2.2%) and Cw3 (15.4 vs. 2.2%). In contrast, B5 was significantly decreased (15.4 vs. 34.8%). In meningioma patients, only B13 was significantly increased (35.0 vs. 6.5%), while in glioma patients, B13 (36.4 vs. 6.5%) and Cw5 (36.4 vs. 2.2%) were significantly increased. Variations between patients and controls have been also encountered for the observed and expected HLA-two locus associations (B13-Cw3, B13-Cw5 and B40-Cw5).
Bibliographic Details
https://bsj.uobaghdad.edu.iq/home/vol9/iss3/14; http://dx.doi.org/10.21123/bsj.2012.9.3.481-490; https://bsj.uobaghdad.edu.iq/cgi/viewcontent.cgi?article=1589&context=home; https://bsj.researchcommons.org/home/vol9/iss3/14; https://bsj.researchcommons.org/cgi/viewcontent.cgi?article=1589&context=home; https://dx.doi.org/10.21123/bsj.2012.9.3.481-490; https://bsj.uobaghdad.edu.iq/home/vol9/iss3/14/
College of Science for Women, University of Baghdad
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know